<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Lavipharm Laboratories, Inc., et al.; Proposal To Withdraw Approval of Five Abbreviated New Drug Applications; Opportunity for a Hearing</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Lavipharm Laboratories, Inc., et al.; Proposal To Withdraw Approval of Five Abbreviated New Drug Applications; Opportunity for a Hearing</h1>
    <p class="timestamp">Published: 2020-09-25 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration's (FDA or Agency) Center for Drug Evaluation and Research (CDER) is proposing to withdraw approval of five abbreviated new drug applications (ANDAs) and is announcing an opportunity for the ANDA holders to request a hearing on this proposal. The basis for the proposal is that the ANDA holders have repeatedly failed to file required annual reports for those ANDAs and have failed to satisfy the requirement to have an approved risk evaluation and mitigation strategy...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-21186</p>
    <p><strong>Publication Date:</strong> 2020-09-25</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/09/25/2020-21186/lavipharm-laboratories-inc-et-al-proposal-to-withdraw-approval-of-five-abbreviated-new-drug">https://www.federalregister.gov/documents/2020/09/25/2020-21186/lavipharm-laboratories-inc-et-al-proposal-to-withdraw-approval-of-five-abbreviated-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-21186</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
